Ciprofloxacin

DNA topoisomerase II alpha ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31711767 Synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives: Antimicrobial activity, DNA Gyrase inhibition and molecular docking. 2020 Jan 2
2 33287922 The effect of Ultraviolet-B irradiation on the photodegradation of ciprofloxacin and norfloxacin as inhibitors of bacterial DNA replication and cell division in urea medium. 2020 Oct 31 1
3 29388638 Developing ciprofloxacin analogues against plant DNA gyrase: a novel herbicide mode of action. 2018 Feb 15 2
4 26100716 Interactions between QnrB, QnrB mutants, and DNA gyrase. 2015 Sep 1
5 21982337 Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study. 2011 Nov 1
6 11469868 Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions. 2001 Aug 3 1
7 8013490 Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients. 1994 Feb 2
8 8186542 Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly. 1994 Feb 1
9 7678175 Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo. 1993 Feb 1
10 1645508 Ciprofloxacin-induced inhibition of topoisomerase II in human lymphoblastoid cells. 1991 Mar 1
11 2842501 Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative. 1988 Sep 1
12 3292209 Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. 1988 Apr 1
13 3293157 Ciprofloxacin: in vitro activity, mechanism of action, and resistance. 1988 May-Jun 2